Related Experiment Videos
Paclitaxel arrests growth of intracellular Toxoplasma gondii
1Department of Medicine, Michael Reese Hospital, Chicago, Illinois 60616, USA.
Abstract:
Addition of paclitaxel (Taxol) at a concentration of 1 microM to Toxoplasma gondii-infected human foreskin fibroblasts arrested parasite multiplication. Division of the T. gondii tachyzoite nucleus was inhibited, leading to syncytium-like parasite structures within the fibroblasts by 24 h after infection and treatment of the cultures. By 4 days after infection and treatment of the cultures with paclitaxel, this inhibition was irreversible, since the arrested intracellular form was incapable of leaving the host cell, infecting new cells, and initiating the growth of tachyzoites with normal morphology. Specifically, when paclitaxel was added to infected cells for 4 days and then removed by washing and the infected, paclitaxel-treated cells were cultured for 4 more days, there were no remaining T. gondii organisms with normal morphology. Syncytium-like structures in the cultures that were infected and treated with paclitaxel for 8 days were similar in appearance to those in preparations of infected paclitaxel-treated fibroblasts that had been cultured for 24 to 48 h. Pretreatment of the tachyzoites for 1 h with paclitaxel followed by the removal of the paclitaxel by repeatedly centrifuging and resuspending the parasites in fresh medium without paclitaxel and then adding fresh medium prior to culture of the parasites with fibroblasts did not prevent their invasion of fibroblasts but did affect their subsequent ability to replicate within fibroblasts. Pretreatment of the fibroblasts with paclitaxel also diminished subsequent replication of T. gondii in such host cells after 8 days. Thus, paclitaxel alters the ability of T. gondii to replicate in host cells. Inhibition of parasite microtubules by such compounds at concentrations which do not interfere with the function of host cell microtubules may be useful for development of novel medicines to treat T. gondii infections in the future.
Insights
Paclitaxel (Taxol) halts Toxoplasma gondii multiplication by inhibiting parasite nuclear division. This drug shows potential for developing new treatments against T. gondii infections.
Area of Science:
- Parasitology
- Cell Biology
- Pharmacology
Background:
- Toxoplasma gondii is an opportunistic parasite causing significant human infections.
- Current treatments for toxoplasmosis have limitations and side effects.
- Understanding parasite-host cell interactions is crucial for developing novel therapies.
Purpose of the Study:
- To investigate the effect of paclitaxel on Toxoplasma gondii replication within human fibroblasts.
- To determine if paclitaxel can inhibit parasite multiplication without harming host cells.
Main Methods:
- Infection of human foreskin fibroblasts with T. gondii tachyzoites.
- Treatment of infected cultures with paclitaxel (1 microM).
- Assessment of parasite morphology, multiplication, and host cell invasion post-treatment.
Main Results:
- Paclitaxel arrested T. gondii multiplication and inhibited nuclear division, forming syncytium-like structures.
- Inhibition was irreversible, with no normal T. gondii observed after 4 days of treatment.
- Pre-treatment of tachyzoites or fibroblasts with paclitaxel also impaired parasite replication.
Conclusions:
- Paclitaxel effectively inhibits T. gondii replication in host cells.
- The drug targets parasite microtubules at concentrations not affecting host cell microtubules.
- Paclitaxel represents a potential candidate for novel anti-Toxoplasma therapies.